Companies: 10,795·Total market cap: $144.5T
Elicio Therapeutics, Inc.

Elicio Therapeutics, Inc.

ELTXNASDAQHealthcare● Active
$13.55
+$0.29(+2.19%)
Market Cap$258616370
P/E Ratio
52W High$14.97
52W Low$7.37
Overview

Elicio Therapeutics, Inc.(ELTX)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

eltx · 股价预测 · 2 位分析师(近3月)· FMP · 更新于 2026年6月9日

分析师评级与共识

基于过去 3 个月内 2 位华尔街分析师

SellBuy

Buy

2 位分析师

共识

评级分布

Strong Buy
0
Buy
1
Hold
1
Sell
0
Strong Sell
0
合计: 2 · 买入占比: 50.0%

12 个月目标价

High

$17.00

Consensus

$17.00

+25.5% upside

Low

$17.00

Median: $17 · Last Close: $13.55

Elicio Therapeutics, Inc.(ELTX)的分析师共识为 Buy,基于过去 3 个月内 2 位华尔街分析师的评级。ELTX 的 12 个月平均目标价为 $17.00,相对当前价 $13.55 代表 +25.5% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足,无法为该股票生成预测图表。

短期股价预测

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-09$14.235.00%

1-day model range: $14.07–$14.39. Peak: $14.39 (+5.00%).

长期股价预测

年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$29+117.1%
2028$47+244.3%
2029$60+345.2%
2030$69+410.4%
2031+447.7%
Confidence:Medium

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

BULLISH

Based on 14 technical indicators

93%0%7%
13Buy
0Neutral
1Sell
RSI (14)75.4Overbought
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · ELTX · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$12.95BUY
MA 10$11.97BUY
MA 20$11.16BUY
MA 50$11.06BUY
MA 100$10.47BUY
MA 200$10.01BUY
Current $ELTX · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$12.99BUY
EMA 10$12.28BUY
EMA 20$11.62BUY
EMA 50$11.11BUY
EMA 100$10.62BUY
EMA 200$9.87BUY
Current $ELTX · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
HC Wainwright & Co.2026-05-28
Maintains
BuyBuy
HC Wainwright & Co.2026-03-13
Maintains
BuyBuy
HC Wainwright & Co.2025-07-17
Maintains
BuyBuy
HC Wainwright & Co.2025-04-02
Maintains
BuyBuy
HC Wainwright & Co.2024-08-23
Maintains
BuyBuy
HC Wainwright & Co.2024-06-06
Maintains
BuyBuy
HC Wainwright & Co.2024-05-22
Maintains
BuyBuy
HC Wainwright & Co.2024-05-01
Maintains
BuyBuy
Oppenheimer2024-04-01
Maintains
PerformPerform
HC Wainwright & Co.2024-01-17
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Elicio Therapeutics, Inc. (ELTX) stock. Of the recent 10 rating actions, 0 were upgrades and 0 were downgrades. 2 analysts currently cover ELTX.

分析师推荐趋势

Buy ratings11
Hold ratings00
Sell ratings00

ELTX analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$20M

Revenue Next Year

$0M

↓ 100.0% YoY

EPS This Year

$-1.95

EPS Next Year

$-1.76

↓ 9.5% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast ELTX EPS of $-1.95 for the current fiscal year, based on estimates from 1 analysts. The ELTX revenue forecast is $20M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

ELTX 股价预测由两类独立数据源支撑:来自 2 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。ELTX 的共识目标价为 $17.00(+25.5% 上行空间),分析师共识为 Buy。

ELTX 的短期预测(明日)为 $14.23(+5.00%)。 ELTX 对 2027 年的股价预测均值为 $29。 ELTX 对 2030 年的预测区间为 $61–$78。

Elicio Therapeutics, Inc. 在 NASDAQ 上市,代码 ELTX。ELTX 在 2027 年的整体展望偏积极,在覆盖分析师中约 50% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

ELTX 预测 · 8 个问题

根据 2 位华尔街分析师,ELTX 的 12 个月平均目标价为 $17.00,最高 $17.00、最低 $17.00。若有图表,中位目标价可在上方查看。相对当前价 $13.55,隐含约 +25.5% 的上行空间。

ELTX 目标价ELTX 分析师目标价ELTX 12个月目标价目标价 ELTX

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.